Latest Press Releases Jan 17 2023 Vertex to Announce Fourth Quarter and Full Year 2022 Financial Results on February 7 Read More Jan 04 2023 Vertex to Present at the 41st Annual J.P. Morgan Healthcare Conference on January 9 Read More Dec 12 2022 Vertex Announces Investigational New Drug (IND) Application for VX-522, mRNA Therapy for People With Cystic Fibrosis, Cleared by FDA Read More Dec 10 2022 Vertex and CRISPR Therapeutics to Present at the American Society of Hematology (ASH) Annual Meeting and Exposition Read More Dec 08 2022 Vertex and Entrada Therapeutics Establish Collaboration to Discover and Develop Endosomal Escape Vehicle (EEV) Therapeutics for Myotonic Dystrophy Type 1 (DM1) Read More Nov 09 2022 Vertex to Participate in Upcoming Investor Conferences Read More Load More Recent Media Library Items View All Date - Any -20212022 Tags Download LibraryImages Our mRNA Investigational Therapy (VX-522) Infographic Download 9 MB Date - Any -20212022 Tags Download LibraryImages Reshma Kewalramani, M.D. Chief Executive Officer and President Download 10 MB Date - Any -20212022 Tags Download LibraryImages Vertex International Headquarters Paddington – Lobby Padding reception entrance Download 915 KB Date - Any -20212022 Tags Download LibraryImages Vertex Logo with Tagline Download 2 MB | 2951 x 1952 Mediainfo@VRTX.com
Jan 17 2023 Vertex to Announce Fourth Quarter and Full Year 2022 Financial Results on February 7 Read More
Jan 04 2023 Vertex to Present at the 41st Annual J.P. Morgan Healthcare Conference on January 9 Read More
Dec 12 2022 Vertex Announces Investigational New Drug (IND) Application for VX-522, mRNA Therapy for People With Cystic Fibrosis, Cleared by FDA Read More
Dec 10 2022 Vertex and CRISPR Therapeutics to Present at the American Society of Hematology (ASH) Annual Meeting and Exposition Read More
Dec 08 2022 Vertex and Entrada Therapeutics Establish Collaboration to Discover and Develop Endosomal Escape Vehicle (EEV) Therapeutics for Myotonic Dystrophy Type 1 (DM1) Read More
